AgingResearch.News
AHA Scientific Sessions 2025 Abstract

Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation

By Bo Zhu, Krishan Gupta, Kui Cui, Show 5 more authorsHong Chen
Experiments in animalsInterventions
Paper

The paper

Bo Zhu, Krishan Gupta, Kui Cui, Show 5 more authorsHong Chen

Boston Children's Hospital

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4358538

doi.org/10.1161/circ.152.suppl_3.4358538

Related